Furthermore, knockdown of Osgin1 and TUBB3 reversed NSCLC tumor progression, and Osgin1 knockdown additionally restored the effect of the anti-cancer drug Gefitinib in tumor suppression [55]. This evidence concerns the gene TUBB3 and non-small cell lung carcinoma.